These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Schelling JR; Ghandour FZ; Strickland TJ; Sedor JR Ren Fail; 1998 Jul; 20(4):635-44. PubMed ID: 9713883 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857 [TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Hande KR; Garrow GC Am J Med; 1993 Feb; 94(2):133-9. PubMed ID: 8430709 [TBL] [Abstract][Full Text] [Related]
6. Acute leukemia in association with Langerhans cell histiocytosis. Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046 [TBL] [Abstract][Full Text] [Related]
7. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Baeksgaard L; Sørensen JB Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435 [TBL] [Abstract][Full Text] [Related]
8. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704 [TBL] [Abstract][Full Text] [Related]
9. Hyperphosphatemia in tumor lysis syndrome: the role of hemodialysis and continuous veno-venous hemofiltration. Sakarcan A; Quigley R Pediatr Nephrol; 1994 Jun; 8(3):351-3. PubMed ID: 7917867 [TBL] [Abstract][Full Text] [Related]
10. Purpuric lesions of the scalp, axillae, and groin of an infant. Khurana M; Leventhal JS; Levy L; McNiff JM; Antaya RJ Cutis; 2017 Jun; 99(6):398;405;406. PubMed ID: 28686757 [No Abstract] [Full Text] [Related]
11. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Narula G; Pradhan ND; Arora B; Banavali SD Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864 [TBL] [Abstract][Full Text] [Related]
13. Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome. Heney D; Essex-Cater A; Brocklebank JT; Bailey CC; Lewis IJ Pediatr Nephrol; 1990 May; 4(3):245-7. PubMed ID: 2400651 [TBL] [Abstract][Full Text] [Related]
14. [Treatment results of Langerhans cell histiocytosis with LSH II protocol]. Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702 [TBL] [Abstract][Full Text] [Related]
15. Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH. Tsuji Y; Kogawa K; Imai K; Kanegane H; Fujimoto J; Nonoyama S Int J Hematol; 2008 Jan; 87(1):75-7. PubMed ID: 18224417 [TBL] [Abstract][Full Text] [Related]